INTRODUCTION
Different methods have been used for the surgical treatment of tricuspid regurgitation. The surgical approach usually involves symmetric and moderate reduction and reconstruction for annulus dilatation and deformation. Annuloplasty should preserve the physiological function of the annulus.
Multiple clinical studies have shown the superiority of remodeling annuloplasty to other repair techniques. The Kalangos biodegradable ring, which was recently developed for mitral and tricuspid annuloplasty, has the advantages of fl exibility, remodeling, and preservation of both the growth potential of the native annulus and the 3-dimensional dynamic geometry [Yavuz 2007] . Among the several techniques described for tricuspid valve repair, the most commonly used technique is De Vega semicircular annuloplasty, which was developed by De Vega and Cabrol to reduce the amount of intracardiac prosthetic material, to provide annular fl exibility, and to reduce the risk of injury of the conduction system [De Vega 1972] . Another repair technique, the Kay-Boyd tricuspid annuloplasty technique, is also used, however [Kay 1965; Boyd 1974] . This technique uses a biodegradable ring with a curved "C" segment consisting of a poly (1,4-dioxanone) polymer that is dyed a blue color and equipped with a stainless steel needle located at each extremity. This ring allows remodeling of the posterior mitral annulus or the anteroposterior tricuspid annulus, with gradual formation of fi brotic tissue during hydrolytic biodegradation. The biodegradable ring was developed for pediatric annuloplasty to preserve the growth potential of the child's heart [Blackstone 1979; Kalangos 2006] . This prospective randomized trial compares the results of biodegradable tricuspid ring annuloplasty and De Vega tricuspid annuloplasty for the surgical treatment of functional tricuspid regurgitation (FTR).
MATERIALS AND METHODS
Between January 2004 and May 2008, 129 patients underwent tricuspid valve repair concomitant with mitral valve replacement or repair and/or other cardiac procedures, such as aortic valve replacement and coronary artery bypass grafting, in the cardiothoracic surgery department of our hospital. Of these patients, 67 (51.5%) underwent annuloplasty with a biodegradable ring (group 1), and 62 patients (48.5%) underwent their surgery with the De Vega tricuspid annuloplasty technique (group 2). Patients were followed with transthoracic echocardiography (TTE) at 1, 12, 18, and 24 months postoperatively. Patients were followed-up for a mean (±SD) of 25.8 ± 7 months (range, 20-36 months). The operations were performed by 2 senior surgeons.
The degree of FTR was determined via the apical 4-chamber view during systole as well as by measuring the 
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Doppler color fl ow jet area of the right atrium ( Figure) . FTR was graded from 1 to 4 (ie, mild, moderate, moderate to severe, and severe). The myocardial performance index (MPI) is a numeric value that can be obtained from cardiac time intervals. The MPI is defi ned as the sum of isovolumetric contraction time (ICT) and the isovolumetric relaxation time (IRT), divided by ejection time (ET), and can be calculated for each ventricle individually. The MPI is higher in severe FTR, and it decreases as FTR improves. It is a visual method for evaluating right ventricle functions.
The patients were followed up at 1, 12, 18, and 24 months postoperatively and were evaluated for effort capacity according to the New York Heart Association (NYHA) class, pulmonary artery pressure (PAP), FTR, MPI, tricuspid stenosis, and the right ventricular end-diastolic diameter.
Operative Technique
A median sternotomy approach was used in all patients. Aortic arterial and bicaval venous cannulation was used in the patients. Antegrade and retrograde cardioplegia cannulas were used in all patients. The vent cannula was inserted through the right superior pulmonary vein.
Rectal temperatures were lowered to the target temperature of 30°C to 32°C during cardiopulmonary bypass. After crossclamping of the aorta, the patients were placed on continuous nonpulsatile perfusion. Isothermic blood cardioplegia was used in all cases. The hematocrit was kept between 20% and 25% during cardiopulmonary bypass. The pump fl ow rate was maintained at 2 to 2.2 L/min per m 2 , and the mean arterial pressure was kept at 50 to 60 mm Hg during cross-clamp application.
Once the repair of the left-system pathologies had been completed, the left atrium was vented with the pulmonary venting cannula, the cross-clamp was removed, and blood was circulated in the heart chambers. This procedure allows the heart to reperfuse and facilitates prompt separation from bypass once the atrium is closed. The right atrium was opened while the inferior and superior vena cavae were cannulated and snared. The tricuspid valve was measured for the appropriately sized ring, and the biodegradable ring was implanted. Selection of the correct ring size is based on the surface area of the anterior leafl et. De Vega annuloplasty was performed with 4-0 pledgeted Prolene suture, and the tricuspid valve was narrowed with double-line suture until normal coaption was acheived. This constriction was performed with Hegar dilators of the appropriate diameter according to a body mass index table [Blackstone 1979 ]. The right atrium was oversewn with continuous 5-0 Prolene suture.
Statistical Analysis
Data are presented as the mean ± SD. Differences between proportions were assessed by the chi-square test; differences between subgroups were compared by 1-way analysis of variance. Logistic regression was used to analyze the correlation of variables. Statistical analysis was performed with SPSS for Windows (version 11.5; SPSS, Chicago, IL, USA). A P value <.05 was considered statistically signifi cant.
RESULTS
Demographic data and risk factors were evaluated preoperatively, and the 2 groups were similar (Tables 1 and 2) . Nineteen patients (29.8%) in the biodegradable ring group (group 1) and 22 patients (40.3%) in the De Vega annuloplasty group (group 2) presented with preoperative atrial fi brillation. The mean preoperative NYHA score was 3.3 (out of 4) in group 1 and 3.5 in group 2.
The PAP was 71 ± 14 mm Hg in group 1 and 69 ± 16 mm Hg in group 2. The PAP showed a rapid decrease postoperatively. At the end of the 24-month follow-up period, the PAP was 37 mm Hg in group 1 and 41 mm Hg in group 2 (Table 3) . At 1 month postoperatively, the FTR ratio was 1.64 (out of 4) in group 1 and 1.68 in group 2. The FRT ratio also decreased during follow-up, and at the end of the 24 months it was 1.37 in group 1 and 1.47 in group 2.
The MPI was 0.61 in group 1 and 0.60 in group 2 at the end of 1 month, but the MPI also decreased by the end of the 24-month follow-up period to 0.40 and 0.50, respectively. The right ventricular end-diastolic diameter (RVEDD) was 36.4 mm in group 1 and 36.1 mm in group 2 at the end of 1 month. The RVEDD decreased to 30.2 mm in group 1 and 34.1 mm in group 2 at the end of the 24-month follow-up.
No infections or thrombotic complications occurred in the groups of our series. According to our postoperative 12-, 18-, and 24-month TTE fi ndings, the function of the tricuspid annulus sphincter was better preserved in group 1. Whereas only 4 patients (5.9%) had 3° recurrence failure in the tricuspid valve in group 1, group 2 had 9 patients (14.5 %) with 3° recurrence failure and 2 patients (3.2%) with 4° recurrence failure. In these patients, persistent pulmonary hypertension, long-term valve disease, and right ventricle dysfunction were considered as risk factors.
DISCUSSION
Seventy percent to 85% of patients with tricuspid valve regurgitation have functional-type regurgitation [Simon 1980; King 1984] . Generally, the regurgitation depends on annular dilatation and the reduction in the systolic annular constriction [Come 1985 ]. Similar dilatation is seen in the mural annular segment and particularly in the posterior annulus (80%) [Carpentier 1974 ]. Isolated tricuspid valve regurgitation is a rare clinical entity. Functional tricuspid valve regurgitation is closely related to the functions of leftside valves, especially mitral valve functions. When the leftside valve dysfunction is fi xed, tricuspid valve regurgitation often resolves and sometimes disappears. Functional tricuspid valve regurgitation has been shown to recover in 47% of patients because of postoperative pulmonary resistance [Pasque 1987 ]. In addition, postoperative functional capacity, which is related to inadequate repair or negligence of the tricuspid valve, is based on the results of mitral valve surgery [Pasque 1987] . Because the tricuspid valve is functioning in a low-pressure system, inaccurate results can be tolerated. A marginal example of this condition is that in the presence of a normal pulmonary pressure and normal right ventricular functions, total excision of the tricuspid valve is possible in patients with tricuspid endocarditis [Pasque 1987] .
Severe or moderate FTR must be corrected surgically owing to the high postoperative morbidity and mortality rates [Simon 1980; King 1984] . There are numerous surgical methods for the treatment of FTR, all of which are aimed at proportional and symmetric reduction and reconstruction of the annulus dilatation and deformation. Different methods have been used for the surgical treatment of tricuspid regurgitation, including replacement with a prosthetic heart valve, suture, and ring annuloplasty. Ring annuloplasty is divided into 2 groups according to whether a fl exible or rigid annuloplasty ring is used. Early and late results of tricuspid annuloplasty are superior to those of valve replacement. Heart valve replacement should be avoided as long as possible [Ege 2002] . Tricuspid valve replacement is limited to patients with valve destruction due to infective endocarditis; however, replacement is not often recommended because it increases the risk of thrombus formation associated with low pressure and valve malfunction [Breyer 1976; Simon 1980] . Th e Heart Surgery Forum #2009-1170
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Even in severe rheumatic diseases, commissurotomy followed by ring annuloplasty is preferred to valve replacement [Breyer 1976 ]. The Kay technique, which is defi ned as tricuspid valve bicuspidalization via plication of the posterior leafl et, is more frequently recommended, although this technique does not protect the valve from annulus dilatation [Kay 1992 ]. The risk of thrombosis around the prosthesis is higher, and long-term and functional results have been demonstrated to be worse in the tricuspid position than in the mitral and aortic positions [Ege 2002 ]. We experienced no thrombosis problems in either of the groups in our series.
Although tricuspid valve correction procedures provide promising results, the fact that a variety of procedures are currently used indicates that uniformly successful methods are not yet available. Postoperative hemodynamic evaluations show a lack of physiological improvement, a persistent residual diastolic gradient in 40% to 50% of cases, and residual tricuspid regurgitation in 30% to 40% of patients [Haerten 1978] . Current annuloplasty techniques have failed to provide a balance between potential tricuspid stenosis associated with a wide constriction of the annulus and persistent residual tricuspid regurgitation due to a limited constriction of the annulus. Use of a biodegradable ring, however, can achieve this balance via measurement of the length of the anterior leafl et and use of the appropriate ring. This approach allows a lower FTR ratio to be obtained in the postoperative follow-up.
Early and medium-term postoperative results after tricuspid valve repair by biodegradable ring annuloplasty have shown that the annulus function and fl exibility of the tricuspid valve are retained [Kalangos 2006 ]. With respect to our patients, the mean MPI scores were 0.64 ± 0.23 and 0.63 ± 0.18 in groups 1 and 2, respectively. Although the postoperative TTE results demonstrated MPI improvement in groups 1 and 2 at 24 months (0.40 and 0.50, respectively), the 46.5% improvement in group 1 was superior to the 37.1% improvement in group 2 (P < .05). This result is also consistent with results described in the literature [Uluçay 2008 ].
According to our postoperative 12-, 18-, and 24-month TTE fi ndings, the sphincter functions of the tricuspid annulus were better preserved in group 1. Whereas only 4 patients (5.9%) in group 1 had 3° recurrence failure in the tricuspid valve, group 2 had 9 patients (14.5%) with 3° recurrence failure and 2 patients (3%) with 4° recurrence failure. In these patients, persistent pulmonary hypertension, long-term valve disease, and right ventricle dysfunction were considered as risk factors.
Right ventricle end-diastolic diameters obtained from the echocardiographic evaluations were also compared. Although the 2 groups were not signifi cantly different in the fi rst month, a statistically signfi cant difference in favor of the biodegradable ring was obtained at the 12-, 18-, and 24-month follow-ups.
Unlike conventional rings placed over the native annulus, the biodegradable ring is inserted into the tissue of the annulus; consequently, the ring has no contact with the systemic blood fl ow. The patient is thus protected from thromboembolic complications. Anticoagulation therapy for 3 months is considered appropriate for patients with a conventional ring until the ring becomes covered with endothelium; however, anticoagulation treatment is not used in patients who receive a biodegradable ring [Kalangos 2006 ]. In addition, the biodegradable ring does not consist of synthetic material; theoretically, it can also be used in cases of mitral valve failure [Kazaz 2005] . No infections or thrombotic complications occurred in the groups of our series. Mild to moderate tricuspid stenosis in 3 patients (4.8%) of the De Vega group, which the TTE results demonstrated at the 12-, 18-, and 24-month followups, was considered a complication.
CONCLUSION
The biodegradable ring annuloplasty technique provides annulus functions that are more physiological in patients with an impaired right ventricle, less recurrence of tricuspid valve regurgitation, no occurrence of iatrogenic stenosis, and better right ventricle functions, according to the mid-term TTE fi ndings. In conjunction with the resolution of the biodegradable ring to fi brotic tissue, the risk of infection and thrombogenicity decreases. In conclusion, we consider the novel annuloplasty technique with a biodegradable ring to be an easy, safe, and promising surgical method for moderate and severe FTR cases.
